Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT MARAVAI LIFESCIENCES HOLDINGS, INC.

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI)
Listen to this Section


$4.98
-0.0150 ( -0.30% ) 780.2K

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Market Data


Open $4.98
Previous Close $4.99
Volume 780.2K
Market Cap $713.93M
Day Range $4.86 - $5.11
52 Week Range $1.99 - $5.21
Shares Outstanding 147.51M
Change % -0.30%
Net Change ▼ -0.0150
Insider Ownership -0.01%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2020
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -11,012,392.00

Date Type Amount Purchased Purchaser
2025-11-13 Buy 157201.00 Brust Bernd
2024-11-14 Buy 17500.00 DeFord John A
2024-11-12 Buy 175000.00 HULL CARL
2024-07-16 Sale -5154.00 Leddy Peter Michael
2024-05-30 Sale -8409946.00 GTCR INVESTMENT XI LLC
2024-05-24 Sale -20645.00 CUNNINGHAM SEAN LAURENCE
2024-05-24 Sale -20645.00 Ashkenazi Anat
2024-05-24 Sale -20645.00 LUCIER GREGORY T
2024-05-24 Sale -20645.00 GRAY SUSANNAH
2024-05-24 Sale -20645.00 DeFord John A

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 18, 2025
4 Insider transactions 1 Jun 18, 2025
4 Insider transactions 1 Jun 10, 2025
3 Insider transactions 2 Jun 10, 2025
8-k 8K-related 15 Jun 09, 2025

Latest News


× Before browsing our site, please accept our cookies policy